Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...

Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...

Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in ...

AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects ...

Envision Pharma Group (Envision) has appointed Darren Coleman as Executive Vice President, Chief Information Officer. Coleman ...

Grifols have announced proof-of-concept data from its Chronos-PD programme, which uses AI, advanced proteomics and real-world ...

Shionogi has dosed the first patients in the phase 2 clinical trial evaluating S-606001, a potential treatment for late-onset ...

Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins ...